Efficacy and safety of allergen immunotherapy in children (Q36404330)

14 August 2017

1 reference

title

Efficacy and safety of allergen immunotherapy in children (English)

1 reference

14 August 2017

1 reference

1

Harold S Nelson

1 reference

14 August 2017

publication date

1 February 2006

1 reference

Annals of Allergy, Asthma & Immunology

14 August 2017

published in

1 reference

14 August 2017

volume

96

1 reference

14 August 2017

issue

2 Suppl 1

1 reference

14 August 2017

page(s)

S2-5

1 reference

Specific immunotherapy in asthma

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Relative risks of bronchial hyper-responsiveness associated with skin-prick test responses to common antigens in young adults

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Asthma severity and morbidity in a population sample of Sydney schoolchildren: Part II--Importance of house dust mite allergens

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Genetic and Environmental Risk Factors for Asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Correlates of recurrent wheezing in school-age children. The Physicians of Raleigh Pediatric Associates

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II)

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

House dust mite allergen in bedroom floor dust and respiratory health of children with asthmatic symptoms

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Mite and cat allergen levels in homes and severity of asthma.

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

House dust mite allergens. A major risk factor for childhood asthma in Australia

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Influence of allergen avoidance on the eosinophil phase of airway inflammation in children with allergic asthma

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Dust mites: immunology, allergic disease, and environmental control.

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Reduction of bronchial hyperreactivity during prolonged allergen avoidance

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Rhinitis and asthma: evidence for respiratory system integration

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Immunotherapy in asthma: an updated systematic review

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Survey of fatalities from skin testing and immunotherapy 1985-1989.

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)60894-0

7 January 2021

10.1016/S1081-1206(10)60894-0

Identifiers

DOI

1 reference

14 August 2017

1 reference